Edition:
United Kingdom

Deena Beasley

Amgen CEO expects 25% of growth to come from Asia in next decade

14 Jan 2020

SAN FRANCISCO Biotechnology giant Amgen Inc expects up to a quarter of its growth to come from Asia over the next decade, Chief Executive Officer Robert Bradway told Reuters.

Biogen builds case for its Alzheimer's drug, skeptics say more data needed

05 Dec 2019

SAN DIEGO/CHICAGO Biogen Inc on Thursday laid out more data on its experimental Alzheimer's drug that raised no major safety alarms but also offered little compelling evidence the drug, once declared a failure, actually works.

UPDATE 3-New Biogen data showed no major safety issues for its Alzheimer's drug

05 Dec 2019

SAN DIEGO/CHICAGO, Dec 5 Biogen Inc on Thursday presented new data on its experimental Alzheimer's drug aducanumab that eased concerns raised by some experts but still left many questions unanswered as the company made its case about why it plans to seek U.S. approval after declaring the drug a failure in March.

Biogen to make case to skeptics for its controversial Alzheimer's drug

05 Dec 2019

SAN DIEGO, Dec 5 Biogen Inc, looking to win over skeptics and health regulators, later on Thursday will present highly anticipated data on its experimental Alzheimer's drug aducanumab, which the U.S. biotech company had declared a failure earlier this year.

Trump nominates MD Anderson oncologist as U.S. FDA Commissioner

01 Nov 2019

U.S. President Donald Trump plans to nominate Dr. Stephen Hahn, chief medical executive of the University of Texas MD Anderson Cancer Center, to lead the Food and Drug Administration, the White House said on Friday.

Amgen takes 20.5% stake in BeiGene to sell cancer drugs in China

31 Oct 2019

LOS ANGELES Amgen Inc said on Thursday it will take a 20.5% stake in BeiGene Ltd in a deal to expand the California-based biotechnology company's presence in China, the world's second largest pharmaceutical market.

Amgen to take 20.5% stake in BeiGene to expand in China

31 Oct 2019

LOS ANGELES, Oct 31 Amgen Inc said on Thursday it will acquire a 20.5% stake in BeiGene Ltd in a deal that will enable the California-based biotechnology company to expand its presence in China, the world's second largest pharmaceutical market.

Amgen posts higher biosimilar sales, ends neuroscience program

29 Oct 2019

Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall Street estimates.

Amgen third-quarter revenue falls 3%, biosimilar sales rise

29 Oct 2019

Oct 29 Amgen Inc on Tuesday said competition for older off-patent drugs sent third-quarter revenue down 3%, but share repurchases and biosimilar sales helped it achieve higher-than-expected profit, and the company raised its full-year outlook.

Mirati drug shrinks tumors in some cancer patients in early-stage trial

28 Oct 2019

An experimental drug from Mirati Therapeutics Inc that targets a specific genetic mutation significantly reduced tumor size in 40% of patients with advanced lung and colorectal cancer so far evaluated in a small, early-stage trial, researchers said on Monday.

World News

China virus death toll mounts to 25, infections spread

A new coronavirus has killed 25 people in China and infected more than 800, the government said on Friday, as the World Health Organisation declared it an emergency but stopped short of declaring the epidemic of international concern.